Ziemssen T - Search Results

1

Management of fingolimod in clinical practice.

Thomas K, Ziemssen T. Thomas K, et al. Among authors: ziemssen t. Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S60-4. doi: 10.1016/j.clineuro.2013.09.023. Clin Neurol Neurosurg. 2013. PMID: 24321158 Review.

2

What can we learn from failed clinical trials in multiple sclerosis?

Ziemssen T. Ziemssen T. J Neurol. 2008 Dec;255 Suppl 6:97-101. doi: 10.1007/s00415-008-6018-6. J Neurol. 2008. PMID: 19300968

3

Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.

Haase R, Schultheiss T, Kempcke R, Thomas K, Ziemssen T. Haase R, et al. Among authors: ziemssen t. J Med Internet Res. 2012 Oct 15;14(5):e135. doi: 10.2196/jmir.2133. J Med Internet Res. 2012. PMID: 23069209 Free PMC article.

4

Modern communication technology skills of patients with multiple sclerosis.

Haase R, Schultheiss T, Kempcke R, Thomas K, Ziemssen T. Haase R, et al. Among authors: ziemssen t. Mult Scler. 2013 Aug;19(9):1240-1. doi: 10.1177/1352458512471882. Epub 2013 Feb 6. Mult Scler. 2013. PMID: 23388164 No abstract available.

5

Cortisol awakening response is linked to disease course and progression in multiple sclerosis.

Kern S, Krause I, Horntrich A, Thomas K, Aderhold J, Ziemssen T. Kern S, et al. Among authors: ziemssen t. PLoS One. 2013 Apr 16;8(4):e60647. doi: 10.1371/journal.pone.0060647. Print 2013. PLoS One. 2013. PMID: 23613736 Free PMC article.

6

Multiple sclerosis documentation system (MSDS): moving from documentation to management of MS patients.

Ziemssen T, Kempcke R, Eulitz M, Großmann L, Suhrbier A, Thomas K, Schultheiss T. Ziemssen T, et al. J Neural Transm (Vienna). 2013 Sep;120 Suppl 1:S61-6. doi: 10.1007/s00702-013-1041-x. Epub 2013 Jun 1. J Neural Transm (Vienna). 2013. PMID: 23728704 Review.

7

Neuroborreliosis during natalizumab treatment in multiple sclerosis.

Thomas K, Schultheiss T, Ziemssen T. Thomas K, et al. Among authors: ziemssen t. Neurology. 2013 Sep 10;81(11):1012-4. doi: 10.1212/WNL.0b013e3182a43b66. Epub 2013 Jul 26. Neurology. 2013. PMID: 23892705

8

Perspectives of an innovative ophthalmological technology: optical coherence tomography (OCT)--what should be of interest to the neurologist?

Ziemssen T, Ziemssen F. Ziemssen T, et al. Among authors: ziemssen f. Clin Neurol Neurosurg. 2013 Dec;115 Suppl 1:S55-9. doi: 10.1016/j.clineuro.2013.09.022. Clin Neurol Neurosurg. 2013. PMID: 24321156 Review.

9

Fingolimod in a patient with heart failure on the background of pulmonary arterial hypertension and coronary artery disease.

Thomas K, Schrötter H, Halank M, Ziemssen T. Thomas K, et al. Among authors: ziemssen t. BMC Neurol. 2014 Jun 7;14:126. doi: 10.1186/1471-2377-14-126. BMC Neurol. 2014. PMID: 24906818 Free PMC article.

10

A 2-year observational study of patients with relapsing-remitting multiple sclerosis converting to glatiramer acetate from other disease-modifying therapies: the COPTIMIZE trial.

Ziemssen T, Bajenaru OA, Carrá A, de Klippel N, de Sá JC, Edland A, Frederiksen JL, Heinzlef O, Karageorgiou KE, Lander Delgado RH, Landtblom AM, Macías Islas MA, Tubridy N, Gilgun-Sherki Y. Ziemssen T, et al. J Neurol. 2014 Nov;261(11):2101-11. doi: 10.1007/s00415-014-7446-0. Epub 2014 Aug 14. J Neurol. 2014. PMID: 25119836 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

479 results

Search Page

Filters